Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nykode Therapeutics ASA Share Issue/Capital Change 2021

Oct 29, 2021

3695_rns_2021-10-29_67210ecd-c7d1-4b31-b708-6d2ad296541f.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Share capital increase from exercise of warrants

Share capital increase from exercise of warrants

As a consequence of the exercise of 170,001 warrants in Vaccibody AS, the share capital of Vaccibody AS has increased by NOK 1,700.01 from NOK 2,870,117.09 to NOK 2,871,817.10. The number of outstanding shares in the company has increased by 170,001 from 287,011,709 to 287,181,710 each with a par value of NOK 0.01. The warrants were exercised by an employee at a strike price of NOK 4.00 per share.